• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PR-350的药代动力学及放射增敏作用

Pharmacokinetics and radiosensitizing effect of PR-350.

作者信息

Hirokawa K, Nakajima T, Tsumura M, Nishita T, Yamada R, Onoyama Y

机构信息

Department of Radiology, Osaka City University Medical School, Osaka, Japan.

出版信息

Radiat Med. 1997 Jan-Feb;15(1):45-9.

PMID:9134584
Abstract

PURPOSE

The in vivo pharmacokinetics and sensitizing effects of PR-350, a newly developed, highly water-soluble radiosensitizer were examined.

MATERIALS AND METHODS

C3H/HeJ mice bearing SCC-VII tumor cells were used in the experiments. Results were compared with those of PR-28 and SR-2508.

RESULTS

The intratumoral concentration of PR-350 reached the maximum value of 77.7 mg/kg 20 min after intravenous injection. The concentration in the brain was below the detection limit. The enhancement ratios of PR-350 calculated using the growth delay method were 0.9 for PR-350 at 50 mg/kg and 1.4 for PR-350 at 100 mg/kg, compared with 1.4 for SR-2508 at 100 mg/kg and 1.0 for PR-28 at 100 mg/kg.

CONCLUSION

PR-350 and SR-2508 revealed similar sensitizing effects. The side effects of PR-350 are expected to be equal to or less than those of SR-2508. PR-350 seems to be a promising radiosensitizer.

摘要

目的

研究新开发的高水溶性放射增敏剂PR - 350的体内药代动力学及增敏作用。

材料与方法

实验采用接种SCC - VII肿瘤细胞的C3H/HeJ小鼠。将结果与PR - 28和SR - 2508的结果进行比较。

结果

静脉注射后20分钟，PR - 350的瘤内浓度达到最大值77.7 mg/kg。脑内浓度低于检测限。采用生长延迟法计算，PR - 350在50 mg/kg时的增敏比为0.9，在100 mg/kg时为1.4；相比之下，SR - 2508在100 mg/kg时为1.4，PR - 28在100 mg/kg时为1.0。

结论

PR - 350和SR - 2508显示出相似的增敏作用。预计PR - 350的副作用等于或小于SR - 2508。PR - 350似乎是一种有前景的放射增敏剂。

相似文献

1
Pharmacokinetics and radiosensitizing effect of PR-350.PR-350的药代动力学及放射增敏作用
Radiat Med. 1997 Jan-Feb;15(1):45-9.
2
[Radiosensitizing effects of nitroimidazole derivative, KIN-804].[硝基咪唑衍生物KIN-804的放射增敏作用]
Nihon Igaku Hoshasen Gakkai Zasshi. 1995 Jan;55(1):70-5.
3
Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.一种新型2-硝基咪唑核苷类似物（PR-350系列）的光学异构体：放射增敏效率与毒性
Int J Radiat Oncol Biol Phys. 1995 Aug 30;33(1):119-27. doi: 10.1016/0360-3016(95)00040-6.
4
[Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].[一种2-硝基咪唑异羟肟酸酯（KIN-804）对小鼠肿瘤的放射增敏作用]
Nihon Igaku Hoshasen Gakkai Zasshi. 1992 May 25;52(5):688-90.
5
Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.从放射增敏和修复抑制潜力方面评估乏氧细胞放射增敏剂。取决于肿瘤细胞的p53状态以及对肿瘤内静止细胞的影响。
Anticancer Res. 2006 Mar-Apr;26(2A):1261-70.
6
Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.米索硝唑和SR-2508对C3H/He小鼠乳腺肿瘤的放射增敏作用研究。
Radiat Med. 1984 Jan-Mar;2(1):71-5.
7
Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor.三氧化二砷诱导实体瘤血管关闭及联合放疗增强疗效的研究。
Radiat Med. 2004 Jul-Aug;22(4):205-11.
8
Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.使用缺氧细胞放射增敏剂多柔比星唑进行单次或分次放射治疗后增强局部肿瘤控制。
Radiother Oncol. 2008 Jun;87(3):331-8. doi: 10.1016/j.radonc.2008.03.002. Epub 2008 Mar 28.
9
In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.硝基咪唑衍生物KIN-804的体内放射增敏作用。
Int J Radiat Oncol Biol Phys. 1994 Jun 15;29(3):601-5. doi: 10.1016/0360-3016(94)90465-0.
10
Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo.缺氧细胞放射增敏剂Ro 7-0582对体内肿瘤细胞的细胞毒性作用。
Radiat Res. 1977 Dec;72(3):469-86.